miR-6077 promotes cisplatin/pemetrexed resistance in lung adenocarcinoma via CDKN1A/cell cycle arrest and KEAP1/ferroptosis pathways

被引:81
作者
Bi, Guoshu [1 ,2 ]
Liang, Jiaqi [1 ,2 ]
Zhao, Mengnan [1 ,2 ]
Zhang, Huan [1 ,2 ]
Jin, Xing [1 ,2 ]
Lu, Tao [1 ,2 ]
Zheng, Yuansheng [1 ,2 ]
Bian, Yunyi [1 ,2 ]
Chen, Zhencong [1 ,2 ]
Huang, Yiwei [1 ,2 ]
Besskaya, Valeria [1 ,2 ]
Zhan, Cheng [1 ,2 ]
Wang, Qun [1 ,2 ]
Tan, Lijie [1 ,2 ]
机构
[1] Fudan Univ, Zhongshan Hosp, Dept Thorac Surg, 180 Fenglin Rd, Shanghai 200032, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Canc Ctr, Shanghai 200032, Peoples R China
基金
上海市自然科学基金;
关键词
OXIDATIVE STRESS; CELL-CYCLE; CISPLATIN RESISTANCE; CANCER CELLS; P21; CRISPR-CAS9; ACTIVATION; THERAPY; DAMAGE; TRIAL;
D O I
10.1016/j.omtn.2022.03.020
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Lung adenocarcinoma (LUAD) is one of the most common malignancies worldwide. Combination chemotherapy with cisplatin (CDDP) plus pemetrexed (PEM) remains the predominant therapeutic regimen; however, chemoresistance greatly limits its curative potential. Here, through CRISPR-Cas9 screening, we identified miR-6077 as a key driver of CDDP/ PEM resistance in LUAD. Functional experiments verified that ectopic overexpression of miR-6077 desensitized LUAD cells to CDDP/PEM in both cell lines and patient-derived xenograft models. Through RNA sequencing in cells and single-cell sequencing of samples from patients with CDDP/PEM treatments, we observed CDDP/PEM-induced upregulation of CDKN1A and KEAP1, which in turn activated cell-cycle arrest and ferroptosis, respectively, thus leading to cell death. Through miRNA pull-down, we identified and validated that miR-6077 targets CDKN1A and KEAP1. Furthermore, we demonstrated that miR-6077 protects LUAD cells from cell ferroptosis, thus resulting in chemoresistance in multiple LUAD cells both in vitro and in vivo. Moreover, we found CDDP/PEM by sponging miR-6077. Collectively, these results imply the critical role of miR-6077 in LUAD's sensitivity to CDDP/PEM, thus providing a novel therapeutic strategy for overcoming chemoresistance in clinical practice.
引用
收藏
页码:366 / 386
页数:21
相关论文
共 78 条
[51]   Role of Nrf2 in Oxidative Stress and Toxicity [J].
Ma, Qiang .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 53, 2013, 2013, 53 :401-+
[52]   Highly Parallel Genome-wide Expression Profiling of Individual Cells Using Nanoliter Droplets [J].
Macosko, Evan Z. ;
Basu, Anindita ;
Satija, Rahul ;
Nemesh, James ;
Shekhar, Karthik ;
Goldman, Melissa ;
Tirosh, Itay ;
Bialas, Allison R. ;
Kamitaki, Nolan ;
Martersteck, Emily M. ;
Trombetta, John J. ;
Weitz, David A. ;
Sanes, Joshua R. ;
Shalek, Alex K. ;
Regev, Aviv ;
McCarroll, Steven A. .
CELL, 2015, 161 (05) :1202-1214
[53]   Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining [J].
Maruyama, Takeshi ;
Dougan, Stephanie K. ;
Truttmann, Matthias C. ;
Bilate, Angelina M. ;
Ingram, Jessica R. ;
Ploegh, Hidde L. .
NATURE BIOTECHNOLOGY, 2015, 33 (05) :538-U260
[54]   Oxidative Stress and Response to Thymidylate Synthase-Targeted Antimetabolites [J].
Ozer, Ufuk ;
Barbour, Karen W. ;
Clinton, Sarah A. ;
Berger, Franklin G. .
MOLECULAR PHARMACOLOGY, 2015, 88 (06) :970-981
[55]   Genome engineering using the CRISPR-Cas9 system [J].
Ran, F. Ann ;
Hsu, Patrick D. ;
Wright, Jason ;
Agarwala, Vineeta ;
Scott, David A. ;
Zhang, Feng .
NATURE PROTOCOLS, 2013, 8 (11) :2281-2308
[56]   limma powers differential expression analyses for RNA-sequencing and microarray studies [J].
Ritchie, Matthew E. ;
Phipson, Belinda ;
Wu, Di ;
Hu, Yifang ;
Law, Charity W. ;
Shi, Wei ;
Smyth, Gordon K. .
NUCLEIC ACIDS RESEARCH, 2015, 43 (07) :e47
[57]   A Randomized Phase 3 Trial Comparing Pemetrexed/Carboplatin and Docetaxel/Carboplatin as First-Line Treatment for Advanced, Nonsquamous Non-small Cell Lung Cancer [J].
Rodrigues-Pereira, Jose ;
Kim, Joo-Hang ;
Magallanes, Manuel ;
Lee, Dae Ho ;
Wang, Jie ;
Ganju, Vinod ;
Martinez-Barrera, Luis ;
Barraclough, Helen ;
van Kooten, Maximiliano ;
Orlando, Mauro .
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (11) :1907-1914
[58]   Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer [J].
Roh, Jong-Lyel ;
Kim, Eun Hye ;
Jang, Hye Jin ;
Park, Jin Young ;
Shin, Daiha .
CANCER LETTERS, 2016, 381 (01) :96-103
[59]   Gambogic acid triggers DNA damage signaling that induces p53/p21Waf1/CIP1 activation through the ATR-Chk1 pathway [J].
Rong, Jing-Jing ;
Hu, Rong ;
Song, Xiu-Ming ;
Ha, Jun ;
Lu, Na ;
Qi, Qi ;
Tao, Lei ;
You, Qi-Dong ;
Guo, Qing-Long .
CANCER LETTERS, 2010, 296 (01) :55-64
[60]   Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells [J].
Shalem, Ophir ;
Sanjana, Neville E. ;
Hartenian, Ella ;
Shi, Xi ;
Scott, David A. ;
Mikkelsen, Tarjei S. ;
Heckl, Dirk ;
Ebert, Benjamin L. ;
Root, David E. ;
Doench, John G. ;
Zhang, Feng .
SCIENCE, 2014, 343 (6166) :84-87